What's Going On With Altamira Therapeutics Stock?
What's Going On With Altamira Therapeutics Stock?
Altamira Therapeutics Ltd. (NASDAQ:CYTO) shares are trading higher Thursday after the company announced highlights from its NASAR clinical trial with Bentrio nasal spray were published in video format on the social media channels of the allergology journal, "Allergy."
Altamira Therapeutics Ltd.（納斯達克股票代碼：CYTO）週四股價走高，此前該公司宣佈，其使用Bentrio鼻腔噴霧劑的NASAR臨床試驗的要點以視頻形式在過敏學期刊《過敏》的社交媒體頻道上發佈。
The Details:
細節：
Altamira's NASAR trial enrolled 100 patients who were randomized at a 1:1 ratio to receive either Bentrio or saline nasal spray. The study met its primary efficacy endpoint, showing a statistically significant reduction in the mean daily reflective Total Nasal Symptom Score (rTNSS), as well as its secondary efficacy endpoints.
阿爾塔米拉的NASAR試驗招收了100名患者，他們以 1:1 的比例隨機分配，接受Bentrio或鹽水鼻腔噴霧劑。該研究達到了其主要療效終點，顯示平均每日反射性總鼻腔症狀評分（RTNS）及其次要療效終點均有統計學上的顯著降低。
"We are delighted to see the great results from the NASAR trial shared by Allergy, one the leading medical journals in allergology, with a large audience through its social media channels," commented Thomas Meyer, Altamira's CEO.
阿爾塔米拉首席執行官托馬斯·邁耶評論說：“我們很高興看到過敏學領域的領先醫學期刊之一《過敏症》通過其社交媒體渠道與廣大受衆分享了NASAR試驗的出色成果。”
"The concept of Bentrio as a drug-free and preservative-free spray forming an efficient protective barrier within the nasal cavity appears to resonate well with allergic rhinitis sufferers. We look forward to making the product available in additional countries and helping more patients deal with the daily burden and discomfort associated with allergic rhinitis."
“Bentrio是一種無藥物、不含防腐劑的噴霧劑，在鼻腔內形成有效的保護屏障，這一概念似乎引起了過敏性鼻炎患者的共鳴。我們期待在更多國家推出該產品，並幫助更多患者應對與過敏性鼻炎相關的日常負擔和不適。”
Altamira shares are moving on heavy trading volume Thursday with more than 48 million shares already changing hands in the session. According to data from Benzinga Pro, the stock's 100-day average volume is 1.157 million shares.
週四，阿爾塔米拉股價交易量居高不下，該交易日已經有超過4,800萬股易手。根據Benzinga Pro的數據，該股的100天平均成交量爲11.57萬股。
Related News: Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb
相關新聞： 專家預測 COVID-19 病例將增加：疫苗庫存攀升
How To Buy CYTO Stock:
如何購買 CYTO 股票：
Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
除了前往經紀平台購買股票的股票（或部分股票）外，您還可以通過購買本身持有股票的交易所交易基金（ETF）來獲得股票，或者將自己分配到401（k）中尋求收購共同基金或其他工具股票的策略。
For example, in Altamira Therapeutics' case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
例如，就阿爾塔米拉療法而言，它屬於醫療保健領域。ETF可能會持有許多有助於追蹤該行業的流動性和大型公司的股票，從而使投資者能夠了解該細分市場的趨勢。
CYTO Price Action: According to Benzinga Pro, Altamira Therapeutics shares are up 27.3% at $1.82 at the time of publication Thursday.
CYTO價格走勢：根據Benzinga Pro的數據，在週四發佈時，Altamira Therapeutics的股價上漲27.3％，至1.82美元。
Image: Shutterstock
圖片：Shutterstock
譯文內容由第三人軟體翻譯。